-
Markets zoom
into record highs. Sensex gains 62 points
- Steady volumes,
negative breadth as FMCG & pharma lead rally
-
Weekly statistics
The
BSE & NSE combined weekly value of shares advancing was Rs. 31,977 crores
( previous week Rs 32,106 crs ) and the commensurate value of shares
declining was Rs. 18,259 crores ( previous week Rs 18,263 crs ). This
indicates a marginal selling bias. The
total weekly traded volume on the BSE was Rs. 14,955 Crores
( previous week Rs 15,396 crs ). The total traded
weekly volume
on the NSE was Rs. 35,483 Crores ( previous week
Rs 35,255 crs ).
The week saw a continuation
of the previous weeks upmove extending to the eighth week of bullishness.
The sentiments were upbeat as the indices created history by notching up
new highs. The market breadth continued to remain negative as the midcap
segment remained under pressure from profit sales. The traded volumes were
comparable to the previous weeks figures with little change. The limelight
shifted to the FMCG & pharmaceuticals sector. The Sensex was boosted
by ACC, Bajaj Auto, Bharti Tele, BHEL, Cipla,
Dr Reddy, HDFC, HDFC Bank, Hind Lever, ITC, ICICI Bank, Infosys, L&T, ONGC,
Reliance Energy, Satyam Computers, SBI, Tata Power and TCS. The Sensex was dragged down by
Grasim, Guj Ambuja Cements, Hero Honda, Hindalco,
MTNL, Maruti, NTPC, Ranbaxy, Reliance Inds, Tisco, Tata Motors and Wipro. The Rupee ended
the week at 43.51 levels (
00.02 ) against the US $. Overall,
the week was completely in line with our expectations.
Click here to view the previous weeks report.
Top I
Derivatives
guide I
Likely triggers I
Technicals I
Reco's I
Print this page
I
Close window
-
The markets are likely
to take note of crude prices which are marginally lower at US $ 58.75 / barrel (
previous week US $ 59.84 / barrel ).
-
The FII investments are
continuing to remain firm as the week saw inflows of Rs 1922.70 Crs
between Mon - Thurs. That will remain the single largest trigger for
the markets.
-
The F&O indicators
point towards a routine paring of exposure on expiry. However, the
Nifty PCR remained higher than average post expiry. This indicates a
high short sale bias even after expiry of the June series.
-
Inflation figure of
4.10 %
is lower than the previous weeks figure of 4.33 %. That is a
positive trigger.
-
The market breadth
points towards a selling bias at higher levels. Of the entire traded volumes of the week, 33
% was initiated on uptick days. That signifies a lack of buying
conviction at higher levels.
-
The overseas markets are
subdued on account of high energy costs and rising interest rates.
That is unlikely to exert any significant influence on the domestic
markets.
-
For a complete
perspective on the market trends, please refer to our editions on f&o,
mid-cap, commodities, currency and crude specials.
Top I
Derivatives
guide I
Likely triggers I
Technicals I
Reco's I
Print this page
I Close window
This
segment is for paid subscribers only
Top I
Derivatives
guide I
Likely triggers I
Technicals I
Reco's I
Print this page
I
Close window
For stock specific recommendations please
refer to our special edition " Flavours of the week".
Click here to view the previous editions of the "Flavours of the week".
Your feedback is
important ! Please
click
here to let us know your views.
Click
here to inform a friend about this page on our website.
- Have a profitable
day.
-
- Vijay L Bhambwani
The author is
a Mumbai based investment consultant and
invites feedback at Vijay@BSPLindia.com
and ( 022 ) 23438482 / 23400345.
SEBI
disclosure - The author
has no positions in the stocks
mentioned above.
Legal
notice :- The Professional
Ticker Reader is a trademark of
Bhambwani Securities (P) Ltd. and any un-authorised replication / duplication in part or full
will be infringing our trademark and
will result in legal action being
enforced on the infringing persons / parties.
- While all due care has
been taken while in compiling the data enclosed herein, we cannot be
held responsible for errors, if any, creeping in. Please
consult an independent qualified investment
advisor before taking investment decisions.
This mail is not sent unsolicited, and only advisory in nature. We
have accepted no consideration from any company mentioned above and
recommend taking decisions on merits of the stocks from our
viewpoint. This email is being sent to you as a paid subscriber.
Please protect your interests and ours by not disclosing the
contents to any un-authorised person/s.
|